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Interaction between the 67 kilodalton metastasis.associated laminin
receptor and laminin. Normal and neoplastic cells interact with laminin
via a variety of cell surface proteins. The specific binding sites on
laminin for each particular cell surface laminin-binding protein have not
yet been identified. In this study, the interaction between laminin and
the high affinity metastasis-associated 67 kD laminin receptor (67 LR)
was investigated by electron microscopy using the rotary shadowing
technique. Laminin receptor that was purified from human colon
carcinoma metastases appeared as a globular structure with a diameter
of 5.2 0.8 nm. The 67 LR specifically bound to laminin on its long arm
close to the intersection of the long and the short arms. There was no
specific interaction of bovine serum albumin with laminin. Biochemical
confirmation of the rotary shadowing experiments included slot blot
solid phase assays in which [I'25]-labeled 67 LR bound in a dose
dependent manner to laminin as well as to the chymotrypsin resistant
(Cl) fragment of laminin that contains a short piece of the long arm.
[I'25]-labeled 67 LR did not bind to the pepsin resistant (P1) fragment of
laminin that did not contain that segment on the long arm. This study
therefore identifies the binding site on laminin for the 67 kD metastasis-
associated laminin receptor as a region on the long arm of laminin close
to the intersection of the four arms.
Interactions between cells and basement membrane are de-
terminant in a variety of normal and pathological cellular
events, including tumor invasion and metastases [1, 2]. Lami-
nm, the major glycoprotein of basement membrane, stimulates
attachment, spreading, migration, proliferation, and differenti-
ation of normal and neoplastic cells [3, 4]. Interactions between
this glycoprotein and cells are mediated through a variety of cell
surface proteins [5—12]. The specific physiological roles of each
of these laminin-binding proteins are still not clear. Among the
several laminin-binding proteins identified, our laboratory has
been studying a 67 kD laminin receptor (67 LR) which has been
purified from several cell lines as well as from normal and
neoplastic tissues [8—101. It appears to be responsible for the
strong affinity of cells for laminin (Kd = 10—) since antibodies
raised against the 67 LR specifically inhibit high affinity binding
of laminin to cells in Scatchard binding assays [12]. The
expression of this receptor is dramatically increased in meta-
static cancer cells compared to their normal or nonmetastatic
counterparts [13—19]. This has been shown both at the protein
level and at the mRNA level [14—19].
Laminin is a macromolecule which exhibits, on rotary-shad-
owing, a cross-shape with three short arms and one long arm
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[201. Cell surface interactions with laminin are crucial during
several steps of the metastatic cascade [1, 21. Previous obser-
vations strongly suggested that the 67 LR is the cell surface
protein that is primarly involved in such interactions [1, 10, 12,
13, 15]. Potential inhibitors of metastasis may be derived from
molecules capable of interfering with the binding of laminin to
neoplastic cells. The identification of the specific binding do-
main on laminin for the metastasis-associated 67 LR may
provide a means to inhibit the metastatic cascade. Previous
experiments, using proteolytically generated laminin fragments,
have suggested that the domain of laminin located around the
intersection of the four arms is crucial for the in vitro attach-
ment of cells to laminin [21, 22] as well as for experimental
metastasis formation [23]. Such experiments have identified
domains of laminin that appear to be essential for cell attach-
ment to laminin and for metastasis formation, but they have not
provided information concerning which specific laminin-binding
protein is involved in binding to the intersection region of
laminin. There have also been reports that a pentapeptide
sequence on the B 1 chain of laminin (YIGSR), predicted by
computer modeling to be on the short arm close to the inter-
section region, is able to inhibit experimental metastasis [24].
Furthermore, YIGSR has been reported to be the binding site
for the 67 LR [25, 26]. However, other studies have presented
contradictory evidence concerning the relationship between
YIGSR and a specific laminin-binding protein [27—291.
In the current study, we have used the rotary shadowing
method and electron microscopy to visualize the specific inter-
action of the 67 kD metastasis-associated laminin receptor with
laminin. We report now the first documented in vitro associa-
tion between laminin and the purified 67 kD metastasis-associ-
ated receptor, as well as the identification of a region on the
long arm of laminin adjacent to the intersection of the four
laminin arms as the specific site of interaction. Binding assays
between the 67 LR and laminin or various proteolytic fragments
strongly support the rotary shadowing electron microscopy
observations.
Methods
Laminin and its fragments P1 and Cl
Laminin was extracted from the mouse Engelbreth-Holm-
Swarm (EHS) tumor in 50 mM Tris, 0.5 M NaCI, pH 7.6, and
was purified by DEAE-cellulose column chromatography as
previously described [30]. Laminin was stored in phosphate
buffered saline (PBS) at —80°C until used. The Cl and P1
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Fig. 2. Rotary shadowing images of laminin and ia,ninin receptor.
Laminin exhibits a cross-shaped structure with one long arm ended by
a globular domain and three short arms, each of which has end globular
domains (panels Al, A2). The 67 kD laminin receptor appears as a
globular structure with a diameter of 5.2 0.8 nm (panel B). Bar, IOU
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Fig. 1. Purification of the 67 kD laminin receptor. Ten micrograms of
receptor eluted from the laminin-Sepharose column with I M NaC1 were
electrophoresed under reducing conditions on a 10% SDS-polyacryl-
amide gel and silver stained, demonstrating a single band located at 67
kD (lane 1). After transfer to Immobilon membrane (Millipore), this 67
kD band was stained by polyclonal antibodies raised against laminin
receptor (lane 2) but not by anti-bovine serum albumin antibodies (lane
3). In control experiments, the anti-albumin antibodies stained bovine
serum albumin (data not shown). Molecular weight standards (in kD
shown to the left) were from Bethesda Research Laboratories.
fragments of laminin were generated respectively by chymo-
trypsin and pepsin digestion of purified laminin according to the
method of Rhode, Bachinger and Timpl [311 and were purified
by gel filtration as described [221. Purity of laminin and its
proteolytic fragments was assessed by SDS-polyacrylamide gel
electrophoresis performed according to the method of Laemmli
[32] as well as by the technique of rotary shadowing.
67 kD laminin receptor
The 67 kD laminin receptor was purified as previously
described [10] from Nonidet P-40 extracts of plasma mem-
branes isolated from human colon carcinoma metastatic tissue
or from placenta. The receptor was eluted from a laminin
affinity column with 1 M NaC1. The purity of the preparation
was assessed by gel electrophoresis and by immunoblot exper-
receptor [331, as well as anti-human and anti-bovine serum
albumin antibodies as a negative control. For binding studies,
the purified 67 kD receptor was radioiodinated ([125J], 13.7
mCiIig, Amersham Co., Arlington Heights, Illinois, USA)
using lodo-beads (Pierce Chemical Co., Rockford, Illinois,
USA) according to the manufacturer's instructions. lodinated
67 LR was recovered by chromatography of the reaction
solution on an Excellulose desalting column (Pierce). The
quality of the iodination was determined by electrophoresis of
the iodinated 67 LR on a 10% SDS-polyacrylamide gel.
Receptor-ligand incubation conditions
Before each experiment, both laminin and laminin receptor
were dialyzed against PBS containing 1 mrvi CaC12 and 1 mM
MgCl2. In control experiments, bovine serum albumin was used
instead of laminin receptor. Incubations were carried out at 4°C
overnight in a volume of 100 il with gentle agitation. Equimolar
(50 nM) amounts of ligand and receptor molecules were used in
most experiments, however, some incubations contained a
10-fold molar excess of laminin receptor and are noted in the
text. The concentration of laminin, laminin P1 and Cl frag-
ments, 67 LR and bovine serum albumin was determined using
the method of Lowry et al [34]. After ligand-receptor incuba-
tions, the samples were diluted with 0.2 M ammonium bicar-
bonate, pH 7.4 and 50% glycerol to a volume of 250 d.
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regions could be clearly observed were used for the quantifica-
tion.
Slot blot semi-solid radioligand assay
Varying amounts of laminin or its P1 or Cl fragments were
blotted on nitrocellulose paper using a Hybri-slot manifold
apparatus (Bethesda Research Laboratories, Gaithesburg,
Maryland, USA). The nitrocellulose paper was first soaked for
five minutes in PBS, mounted in the apparatus on a piece of
Whatman filter paper, and the different glycoproteins, in 200p1
of PBS, were vacuum filtered onto the nitrocellulose paper.
After blotting, the nitrocellulose paper was blocked for one
hour at room temperature in a solution of PBS containing 2%
BSA and 1 mri CHAPS, and incubated for four hours at 4°C in
the same solution containing i'251}-labeled 67 LR. After incu-
bation, the nitrocellulose paper was washed five times for 10
minutes each in PBS, 2% BSA, 1 mrvi CHAPS; the filter was
air-dried, autoradiographed and the binding was quantified
using an LKB 2202 Ultroscan Laser Densitometer on multiple
autoradiographs of various exposures to ensure that the signal
was in the linear response range.
Results
Purfi cation of the 67 LR
Fig. 3. Electrophorezic analysis of laminin and 67 LR. SDS-polyacryl-
amide gel of purified laminin (lane 1), laminin receptor (lane 2), and a
mixture of laminin and laminin receptor in 10 fold molar excess (lane 3).
Molecular weight standards (in kD shown to the left) were from
Bethesda Research Laboratories.
Rotary shadowing
Samples were processed according to the technique de-
scribed by Shotton, Burke and Branton [35]. Briefly, the total
protein concentration was brought to 80 g/ml in 0.2 M ammo-
nium bicarbonate, pH 7.4 and 50% glycerol. The samples were
sprayed onto freshly cleaved mica from a distance of 20 cm.
The material was then transferred onto the rotating stage of a
Ladd vacuum evaporator and the proteins were shadowed,
under a pressure of 2 x iQ torr, with a mixture of platinum!
palladium at an angle of 6°, followed by coating with carbon at
an angle of 90°. Replicas were allowed to float on distilled water
and were picked up on copper grids.
Quantification of the morphological data
The grids were examined by using a Phillips 400 electron
microscope, operating at 60 kY. The percentage of association
between laminin or its P1 fragment and laminin receptor or
bovine serum albumin was determined by direct observation of
the replica and counting of the molecules. Only those molecules
of spread laminin in which all four arms and globular end
Laminin receptor eluted from a laminin-Sepharose column
with 1 M NaCl exhibited an apparent molecular mass of 67,000
on reduced SDS-polyacrylamide gels and specifically reacted
with anti-lamjnin receptor antibodies but not with anti-bovine
serum albumin antibodies (Fig. 1). As previously observed [20],
the rotary shadow replicas of laminin show that this macromol-
ecule exhibits a cross-shaped structure with three short arms
and one long arm with one globular end region (Fig. 2A). The
two short arms perpendicular to the long arm exhibit two
globular end regions while three globular end areas can be seen
on the short arm prolongating the long arm. Using the same
technique, the 67 LR appears as a globular structure with a
diameter of 5.2 0.8 nm (Fig. 2B). Figure 3 shows the
electrophoretic pattern on a 10% SDS-polyacrylamide gel of
laminin (lane 1), laminin receptor (lane 2), and incubation
mixture of laminin and a 10-fold molar excess of receptor (lane
3). The preparation of laminin did not contain detectable
amounts of entactin/nidogen.
Rotary shadowing electron microscopy analysis of laminin-67
LR complexes
When equimolar amounts of intact laminin and the 67 LR
were incubated together at 4°C and then examined using the
rotary shadowing technique, the ligand and the receptor inter-
acted to form distinct complexes. Figure 4 shows selected
examples of laminin-laminin receptor associations in which
laminin receptor molecules specifically bound to the long arm of
laminin close to the intersection of the four arms. In all the
cases observed, only one laminin receptor was specifically
bound to one molecule of laminin. Binding of the 67 LR to other
areas of the laminin molecule was an unusual event (see below,
Fig. 5). To demonstrate that the binding of laminin receptor to
laminin on its long arm just below the intersection was specific,
we analyzed over 155 molecules by direct examination of the
replicas following the criteria defined in Methods. From these
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Fig. 4. Images obtained by rotary shadowing of a mixture of laminin and 67 LR. Laminin receptor binds to laminin on its long arm just below the
intersection area. Panel Al shows a field in which there are four molecules of laininin, to each of which one molecule of laminin receptor is
specifically attached. Panel A2 depicts line-drawings of the associated molecules; the laminin receptor is represented by the open circle. Panels Bi
toB8 depict 8 out of the 132 observed ligand-receptor complexes. Arrows point to the laminin receptor. Bar, 100 nm.
molecules observed. The data, summarized in Figure 5, clearly
show that the binding of laminin receptor to the long arm of
laminin just below the intersection is the most frequent event,
occurring in 85% of the total number of laminin molecules
observed and in 96.5% of the total number of laminin-laminin
receptor complexes examined. The other interactions between
laminin and laminin receptor could be divided into three general high frequency of complexes in which laminin receptor bound
receptor binds to any region of the short arm of laminin which
appears as the extension of the long arm, and (c) complexes in
which the receptor binds to a region of the long arm distant from
the intersection. Neither of these three types of complexes was
observed at high frequency. Among the laminin molecules
observed, only 12% were laminin receptor-free (Fig. 5). The
data, we calculated the relative frequency of specific laminin-67
LR associations as a percentage of the total number of laminin
groups: (a) complexes in which the 67 LR binds to any region of
the lateral short arms of laminin, (b) complexes in which the
t t t t t
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Fig. 5. Histogram of the relative frequency of
specific laminin-laminin receptor complexes.
One hundred and fifty-five laminin molecules
were observed using criteria described in
Methods. Four types of associations were
observed as described in the text. The
frequency of each type of association is
presented as a percentage of the total number
of laminin molecules. The laminin receptor is
represented by hatched circles.
to the long arm immediately below the intersection was not
affected by increasing the relative amount of receptor to 10-fold
molar excess during the laminin-laminin receptor incubation.
To determine whether the area of the long arm of laminin
located just below the intersection was the specific site of
interaction between laminin and the 67 LR, Cl and P1 frag-
ments of laminin were generated by digestion of laminin with
chymotrypsin or pepsin, respectively. As shown in Figure 6A,
the pepsin-resistant (P1) fragment of laminin includes neither
the long arm nor the globular ends of the short arms. When the
P1 fragment of laminin was incubated overnight at 4°C with a
10-fold molar excess of laminin receptor, the rotary shadow
replicas of the mixtures showed no specific interaction between
the two molecules (Fig. 6B). In control ligand-receptor incuba-
tions, we replaced the 67 LR with 68 kD bovine serum albumin.
No interactions were found between laminin and bovine serum
albumin (Fig. 7).
lodinated 67 LR binds to laminin and its CI fragment, but
not to irs P1 fragment, in a slot blot assay
To biochemically support the rotary shadowing electron
microscopy data showing that the 67 LR binds to laminin on the
long arm close to the intersection of its arms, we developed a
semi-solid slot blot binding assay. lodinated 67 LR was incu-
bated with varying amounts of laminin, laminin Cl fragment or
laminin P1 fragment immobilized on nitrocellulose paper as
described in Methods. In contrast to the P1 fragment, the Cl
fragment includes a short portion of the long arm immediately
adjacent to the cross section of the laminin arms. Figure 8
shows that the iodinated 67 LR bound, in a dose dependent
manner, to intact laminin as well as to its Cl fragment but did
not interact with the laminin P1 fragment.
Discussion
In this manuscript, we describe for the first time the in vitro
association of laminin with purified 67 LR, visualized by the
technique of rotary shadowing and electron microscopy. This
method has been previously used to investigate the interactions
between laminin and type IV collagen [36, 371. The laminin
receptor bound specifically to the long arm of laminin just below
the intersection of the four arms, suggesting that this region of
the long arm may be crucial for the interaction between laminin
and the 67 kD metastasis-associated laminin receptor. Indeed,
the receptor did not bind in either rotary shadowing or solid
phase binding assays to the P1 fragment of laminin which does
not encompass the long arm. The importance of the intersection
region of the long arm for the interaction of neoplastic cells with
laminin was previously suggested by studies showing that a
chymotrypsin-resistant fragment of laminin (which does include
a short segment of the long arm immediately adjacent to the
cross section) bound with high affinity to the surface of mela-
noma cells and prevented the formation of experimental metas-
tases [21, 23]. Biochemical confirmation of the morphologic
studies was provided by the observation that iodinated 67 LR
bound to immobilized laminin and its Cl fragment but not to its
P1 fragment. The interaction of the 67 LR with the intersection
area of the long arm of laminin is specific. Indeed, bovine serum
albumin, which has a similar molecular weight as laminin
receptor, did not interact with laininin under our experimental
conditions.
When incubated in equimolar amounts, 85% of the laminin
molecules have one laminin receptor molecule attached to the
long arm just below the intersection area. The 67 LR thus
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Fig. 6. P1 fragment of laminin and its interaction with taminin recep-
sr. A. Typical rotary shadowing replica of three P1 laminin fragments.
The long arm is completely digested as well as the globular end domains
of the short arms. B. Mixture of P1 laminin fragment with a 10-fold
molar excess of laminin receptor. The arrows point to two of the many
receptor molecules in this field. No specific interaction between the P1
fragments and laminin receptor was observed. Bar, 100 nm.
interacts with laminin with a 1:1 stoichiometry. This is interest-
ing in light of our recent finding that peptide G, a 20 amino acid
synthetic peptide derived from the 67 LR cDNA sequence and
which contains the 67 LR binding site for laminin, also interacts
with a 1:1 stoichiometry to laminin [27]. The high incidence of
specific association of laminin with laminin receptor, even when
the two molecules are present at a ratio of 1:1, is consistent with
the hypothesis that the 67 kD laminin receptor is responsible for
the high affinity binding of cells to laminin [12, 16]. Other
laminin-binding proteins have been identified [5—12]. These
proteins may interact with laminin in regions distinct from the
intersection region [38, 39]. Nurcombe et a! [39], for example,
have reported a putative binding site on the long arm of laminin
close to the globular end region. Our results clearly indicate that
the 67 LR does not specifically interact with this region. It is
interesting to speculate that other laminin-binding proteins
interact with different domains of laminin, each with different
affinities and distinct physiological effects on cell behavior. It is
Fig. 7. interaction between laminin and bovine serum atbumin. Lami-
nm and bovine serum albumin were incubated overnight as described in
Methods, and the mixture was visualized by rotary shadowing and
electron microscopy. Panels A and B depict two typical fields. The
arrows point to a molecule of albumin. No interaction was visualized
between laminin and bovine serum albumin after an overnight incuba-
tion. Bar, 100 nm.
not possible at this time to determine if this binding site involves
the Bi, B2, or A chain of laminin, or a combination of
associated chains.
A short sequence of the B! chain of laminin, the pentapeptide
YIGSR, has been reported to be the potential binding site for
the 67 LR on laminin and to inhibit cell attachment to laminin as
well as experimental metastasis formation [24—26]. According
to the latest computer-derived model of laminin [4], YIGSR is
located on the short arm, immediately adjacent to the intersec-
tion region. The rotary shadowing replicas that we observed in
this report clearly suggest that the 67 kD receptor binding area
is on the long arm just below the intersection. We cannot rule
out, at this time, the possibility that the YIGSR pentapeptide is
actually located on the long arm of laminin, and not, as
predicted by computer modeling, on the B1 short arm. How-
ever, there are now several studies that have failed to demon-
strated a relationship between the 67 LR and YIGSR [27—29].
There is now growing evidence that the 67 LR is intimately
II
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Fig. 8. 67 LR specifically bind to laminin and its CI fragment, but not to its P1 fragment, in slot-blot assays. (A) Autoradiogram of 125I]67 LR
binding to laminin, laminin Cl and P1 fragments in a slot-blot assay. These glycoproteins were absorbed onto nitrocellulose in amounts ranging
from 0.1 to 1 g. The nitrocellulose filter was incubated with [125I}67 LR and processed as described in Methods. (B) The binding of 67 LR to
laminin (circle), laminin Cl fragment (square) and laminin P1 fragment (triangle) was quantified by densitometry as described in Methods.
associated with the metastatic potential of cancer cells, espe-
cially in human breast and colon adenocarcinomas [15, 19].
Highly metastatic human colon cancer cells have higher levels
of laminin receptor mRNA than do their non- or less metastatic
counterparts [13, 17, 19]. Human metastatic breast cancer cells
express more laminin receptor at their surface than nonmeta-
static or normal cells [15, 16, 18]. Furthermore, estrogen and
progestins, known to modulate breast cancer development,
significantly stimulate the expression of the 67 LR both at the
protein and mRNA level [14]. In this study we provide direct
evidence, using the rotary shadowing technique, that the 67 LR
is able to interact specifically with laminin. In addition, we have
identified the 67 LR binding site on laminin to be on the long
arm close to the intersection of the four arms. This domain of
laminin has been demonstrated to play a crucial role in the in
vitro attachment of cells to laminin [221 as well as for experi-
mental metastasis formation [21, 23]. The identification of this
domain of laminin as the binding site for the 67 LR provides
further evidence that the 67 LR plays a crucial role in cellular
interactions with laminin during the metastatic cascade. The
characterization of this binding site on laminin should facilitate
research attempts to generate specific inhibitors of the meta-
static cascade.
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